High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia

被引:0
|
作者
Jun Li
Zheng Ge
机构
[1] Medical School of Southeast University,Department of Hematology, Zhongda Hospita
[2] Institute of Hematology Southeast University,Hershey Medical Center
[3] Pennsylvania State University Medical College,undefined
来源
BMC Cancer | / 21卷
关键词
AML; Prognosis; Biomarker; Oncogene;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia
    Li, Jun
    Ge, Zheng
    BMC CANCER, 2021, 21 (01)
  • [2] High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia
    Zheng, Yongzhi
    Huang, Yan
    Le, Shaohua
    Zheng, Hao
    Hua, Xueling
    Chen, Zaisheng
    Feng, Xiaoqin
    Li, Chunfu
    Zheng, Mincui
    Xu, Honggui
    He, Yingyi
    He, Xiangling
    Li, Jian
    Hu, Jianda
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia
    Shi, Jinlong
    Fu, Huaping
    Jia, Zhilong
    He, Kunlun
    Fu, Lin
    Wang, Weidong
    EBIOMEDICINE, 2016, 14 : 55 - 64
  • [4] High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
    Fu, Lin
    Fu, Huaping
    Qiao, Jianlin
    Pang, Yifan
    Xu, Keman
    Zhou, Lei
    Wu, Qingyun
    Li, Zhenyu
    Ke, Xiaoyan
    Xu, Kailin
    Shi, Jinlong
    CANCER SCIENCE, 2017, 108 (09): : 1850 - 1857
  • [5] High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia
    Liu, Yan
    Lu, Rongjian
    Cui, Wei
    Pang, Yifan
    Liu, Chaojun
    Cui, Longzhen
    Qian, Tingting
    Quan, Liang
    Dai, Yifeng
    Jiao, Yang
    Pan, Yue
    Ye, Xu
    Shi, Jinlong
    Cheng, Zhiheng
    Fu, Lin
    CANCER GENE THERAPY, 2020, 27 (1-2) : 38 - 44
  • [6] High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia
    Yan Liu
    Rongjian Lu
    Wei Cui
    Yifan Pang
    Chaojun Liu
    Longzhen Cui
    Tingting Qian
    Liang Quan
    Yifeng Dai
    Yang Jiao
    Yue Pan
    Xu Ye
    Jinlong Shi
    Zhiheng Cheng
    Lin Fu
    Cancer Gene Therapy, 2020, 27 : 38 - 44
  • [7] OPTIMAL COMBINATION OF IMMUNE CHECKPOINTS PREDICTS ADVERSE OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Li, Yangqiu
    Chen, Cunte
    Liang, Chaofeng
    Wang, Shunqing
    Chio, Chi Leong
    Zhang, Yuping
    Zeng, Chengwu
    Chen, Shaohua
    Wang, Caixia
    Li, Yangqiu
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : S70 - S70
  • [8] High Expression of Microtubule-associated Protein TBCB Predicts Adverse Outcome and Immunosuppression in Acute Myeloid Leukemia
    Wang, Bichen
    Wang, Wenjun
    Li, Qiaoli
    Guo, Tengxiao
    Yang, Shuang
    Shi, Jun
    Yuan, Weiping
    Chu, Yajing
    JOURNAL OF CANCER, 2023, 14 (10): : 1707 - 1724
  • [9] High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia
    Miriam Marquis
    Cyrielle Beaubois
    Vincent-Philippe Lavallée
    Michal Abrahamowicz
    Coraline Danieli
    Sébastien Lemieux
    Imran Ahmad
    Andrew Wei
    Stephen B. Ting
    Shaun Fleming
    Anthony Schwarer
    David Grimwade
    William Grey
    Robert K. Hills
    Paresh Vyas
    Nigel Russell
    Guy Sauvageau
    Josée Hébert
    Blood Cancer Journal, 8
  • [10] High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemia
    Marquis, Miriam
    Beaubois, Cyrielle
    Lavallee, Vincent-Philippe
    Abrahamowicz, Michal
    Danieli, Coraline
    Lemieux, Sebastien
    Ahmad, Imran
    Wei, Andrew
    Ting, Stephen B.
    Fleming, Shaun
    Schwarer, Anthony
    Grimwade, David
    Grey, William
    Hills, Robert K.
    Vyas, Paresh
    Russell, Nigel
    Sauvageau, Guy
    Hebert, Josee
    BLOOD CANCER JOURNAL, 2018, 8